Solian: Advanced Atypical Antipsychotic for Schizophrenia Management
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.25 | $97.39 (0%) | 🛒 Add to cart |
| 60 | $2.98 | $194.79 $178.72 (8%) | 🛒 Add to cart |
| 90 | $2.89 | $292.18 $260.05 (11%) | 🛒 Add to cart |
| 120 | $2.85 | $389.57 $342.38 (12%) | 🛒 Add to cart |
| 180 | $2.80 | $584.36 $504.04 (14%) | 🛒 Add to cart |
| 270 | $2.77
Best per pill | $876.54 $748.02 (15%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.98 | $89.36 (0%) | 🛒 Add to cart |
| 60 | $2.73 | $178.72 $163.66 (8%) | 🛒 Add to cart |
| 90 | $2.64 | $268.08 $237.96 (11%) | 🛒 Add to cart |
| 120 | $2.60 | $357.44 $312.26 (13%) | 🛒 Add to cart |
| 180 | $2.55 | $536.16 $459.86 (14%) | 🛒 Add to cart |
| 270 | $2.53
Best per pill | $804.25 $683.76 (15%) | 🛒 Add to cart |
Synonyms | |||
Solian (amisulpride) is a modern atypical antipsychotic medication designed for the effective management of schizophrenia and related psychotic disorders. It functions by selectively blocking dopamine D2 and D3 receptors in the brain, which helps restore neurotransmitter balance and reduce positive and negative symptoms of psychosis. Clinically proven to enhance cognitive function and social engagement, Solian offers a favorable side effect profile with a lower risk of extrapyramidal symptoms compared to conventional antipsychotics. Its flexible dosing and reliable pharmacokinetics make it a cornerstone in long-term psychiatric treatment plans, supporting both acute intervention and maintenance therapy.
Features
- Active ingredient: Amisulpride
- Available in 50 mg, 100 mg, 200 mg, and 400 mg film-coated tablets
- Selective dopamine D2/D3 receptor antagonist
- High oral bioavailability (~77%)
- Linear pharmacokinetics with dose proportionality
- Elimination half-life of approximately 12 hours
- Minimal hepatic metabolism; primarily excreted unchanged in urine
- Low protein binding (~16%)
- Manufactured under GMP standards
Benefits
- Effectively reduces positive symptoms such as hallucinations, delusions, and thought disorders
- Improves negative symptoms including social withdrawal, apathy, and blunted affect
- Enhances overall quality of life and functional recovery
- Lower incidence of extrapyramidal side effects and weight gain compared to some other antipsychotics
- Supports long-term remission and relapse prevention
- Flexible dosing allows for personalized treatment regimens
Common use
Solian is primarily indicated for the treatment of schizophrenia in adults. It is effective against both acute episodes and maintenance therapy to prevent relapse. It may also be used off-label in some jurisdictions for dysthymia and other mood disorders, though such use should be carefully evaluated by a specialist. Clinical studies demonstrate its efficacy in improving overall psychosocial functioning, making it suitable for patients requiring sustained antipsychotic therapy.
Dosage and direction
Dosage must be individualized based on symptom profile, patient response, and tolerability. For positive symptoms, the recommended dose is 400–800 mg/day, administered in two divided doses. Doses above 400 mg/day may increase the risk of side effects. For predominant negative symptoms, lower doses of 50–300 mg/day are often effective. Tablets should be swallowed whole with water, preferably before meals. Dosage adjustments are necessary in patients with renal impairment. Treatment should be initiated under specialist supervision, with regular evaluation of efficacy and safety.
Precautions
Use with caution in patients with cardiovascular disease, seizure disorders, or Parkinson’s disease. Solian may cause sedation; patients should avoid driving or operating machinery until their response is known. Regular monitoring of weight, blood glucose, lipid profile, and prolactin levels is advised. Elderly patients and those with renal impairment require dose reduction. Solian should not be used during pregnancy unless clearly needed, and breastfeeding is not recommended. Alcohol should be avoided during treatment.
Contraindications
Hypersensitivity to amisulpride or any excipients; pheochromocytoma; prolactin-dependent tumors; concomitant use with levodopa; severe renal impairment (creatinine clearance <10 mL/min). Solian is contraindicated in children and adolescents under 15 years of age.
Possible side effects
Common (≥1/10): insomnia, anxiety, agitation, hyperkinesia, dry mouth, constipation.
Less common (≥1/100, <1/10): extrapyramidal symptoms, elevated prolactin, weight gain, hypotension, bradycardia, QT prolongation.
Rare (<1/1000): neuroleptic malignant syndrome, tardive dyskinesia, seizures, allergic reactions.
Most side effects are dose-dependent and may resolve with dose adjustment or over time.
Drug interaction
Solian may interact with:
- Other antipsychotics (increased risk of extrapyramidal symptoms and QT prolongation)
- Levodopa and dopamine agonists (reduced efficacy)
- Drugs that prolong QT interval (e.g., antiarrhythmics, certain antibiotics)
- Alcohol and CNS depressants (additive sedative effects)
- Medications that inhibit renal excretion (e.g., cimetidine)
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one.
Overdose
Symptoms may include severe sedation, hypotension, extrapyramidal symptoms, and QT prolongation. Management is supportive; there is no specific antidote. Gastric lavage may be considered if ingestion was recent. ECG monitoring is essential. Contact a poison control center or seek emergency medical attention immediately.
Storage
Store below 30°C (86°F), in the original packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized medical guidance. Do not discontinue or adjust medication without medical supervision.
Reviews
Clinical trials and post-marketing studies consistently report Solian as effective and well-tolerated. Many patients experience significant symptom reduction with fewer metabolic side effects than with some other antipsychotics. Some users note improved motivation and social functioning. However, individual responses vary, and prolactin elevation may be a concern for some. Long-term adherence is generally favorable when monitored appropriately.